ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626669 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626669; 2) Community: the network communities that were significantly associated with the response to NSC 626669; 3) Molecule: the relationships between components within communities and NSC 626669; 4) MDR: the compounds that were significantly associated with the NSC 626669.

NSC Compound Enrichment Correlation
NSC 701023 Aceanthryleno[1,2-b]quinoxaline, 12-nitro- 0.0352028253287042 0.17068459
NSC 709974 Null 0.0352028253287042 0.23573016
NSC 718630 Null 0.0352028253287042 0.071725851
NSC 726217 Combretastatin A4-analogue 0.0352028253287042 0.11680067
NSC 733476 Null 0.0352028253287042 0.3504058
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0352028253287042 0.34827844
NSC 743695 Null 0.0352028253287042 0.11169285
NSC 749169 8H-thieno[2'3':4,5]pyrimido[2,1-a]phthalazin-8-one,5-[[3-(dimethylamino)propyl]amino]-9,10-dimethyl 0.0352028253287042 -0.02354385
NSC 750154 salarin C 0.0352028253287042 -0.20813929
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0352028253287042 0.23830071
Total:70  Current:47    [First] [Prev] [Next] [Last]